Testosterone Cypionate + Progesterone — Class II drug recall D-1040-2017
Terminated recall by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical, reported 2017-08-09, distributed in CA. CGMP Deviations
| Recall number | D-1040-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical, Los Angeles, CA, United States |
| Recall initiated | 2017-07-12 |
| Classified | 2017-07-31 |
| Reported by FDA | 2017-08-09 |
| Terminated | 2019-01-14 |
| Distributed | CA |
| Quantity | 120 vials |
| Reason classes | cgmp |
| Expiration dates | 2017-08-29 |
Product
Testosterone Cypionate + Progesterone, 200 mg/ 2.5 mg/mL ,10 mL amber glass vials, Rx Only, Compounded by AXIA Pharmaceutical, Los Angeles, CA 90025
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1040-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.